Megaloblastic Anemia

Megaloblastic anemia is a type of anemia caused by a deficiency in either folic acid or vitamin B12. This deficiency results in an increased production of abnormally large red blood cells. If left untreated, the body is unable to produce enough functional red blood cells, leading to a number of symptoms including fatigue, loss of appetite, pale skin, and weight loss. Megaloblastic anemia is a serious condition, and if left untreated, can lead to complications such as neurological damage or heart failure. Treatment typically includes supplementation with folic acid or vitamin B12, as well as receiving regular blood transfusions. Early diagnosis and prompt treatment is important to prevent further complications.

← Journal of Bone Marrow Biology

Related Articles

2 article(s) found

Molecular Study of Hepcidin HAMP (-582A/G) Gene Polymorphisms and Measurement of Serum Hepcidin Level among Sudanese Patients with Anemia of Chronic Kidney Disease

Full-text HTML Download PDF Download XML

Prolonged survival of Diamond-Blackfan anemia and RPS19 mutation: an observation in Togo

Full-text HTML Download PDF Download XML